ClinicalTrials.gg
Drug

Repaglinide clinical trials

Also written Prandin®.

studies test it
41
open now
3
in phase 3
2
first study started
2001

How each study uses repaglinide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the repaglinide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Dec 1997 · PRANDIN · NDA 020741 (FDA, Drugs@FDA)
European Union
16 Aug 1998 · NovoNorm · EMEA/H/C/000187 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Repaglinide
35
NovoNorm
2

Brand

Prandin®
3

Studies by the year they started

41 studies that test it; most in 2009 (5)

Studies that test repaglinide, by start year
YearStudies
20014
20024
20034
20052
20064
20095
20122
20131
20141
20181
20191
20202
20211
20221
20244
20252
20262

By phase

A phase 1/2 study counts in both.

Phase 1
19
Phase 2
1
Phase 3
2
Phase 4
15
No phase
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 10

Novo Nordisk A/S (12) · Eli Lilly and Company (2) · Jiangsu HengRui Medicine Co., Ltd. (2) · Novartis Pharmaceuticals (2) · Steno Diabetes Center Copenhagen (2) · Institut de Recherches Internationales Servier (I.R.I.S.) (1) · AstraZeneca (1) · DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company (1)

Often tested with

Tested in the same studies.

Metformin (9) · Midazolam (4) · Acarbose (3) · Bupropion (2) · Atorvastatin (2) · Insulin, Isophane (2) · Gliclazide (2) · Glyburide (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test repaglinide.

Studies

Open first, then newest update. How each study uses repaglinide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 41

See all 41 studies that test repaglinide →

Given beside what is tested · 16 — repaglinide is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with repaglinide

Codes

What other systems call repaglinide · ClinicalTrials.gg INT003605

  • MeSH (NLM) C072379repaglinideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 668Z8C33LUREPAGLINIDEConfirmed FDA, NLM, Wikidata
  • UNII (FDA) 85M30X62FMREPAGLINIDE, (-)-Confirmed NLM, Wikidata
  • RxNorm 73044Confirmed FDA, Wikidata
  • Wikidata Q2195995repaglinideConfirmed FDA, NLM, Wikidata
  • Wikidata Q27269656(-)-repaglinideConfirmed NLM, Wikidata
  • NCI Thesaurus C47703RepaglinideOne source FDA
  • DrugBank DB00912One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.